Literature DB >> 23972718

Fourteen years of debate and workshops on the immunology of preeclampsia. Where are we now after the 2012 workshop?

Pierre-Yves Robillard1, Gustaaf Dekker2, Gérard Chaouat3.   

Abstract

This paper depicts an overview of debates that have taken place during the 14 years of the International Workshops on Reproductive Immunology/Immunological Tolerance and Immunology of Preeclampsia. This 8th event in 2012 (Reunion island, overseas department of France in the Indian Ocean) witnessed a consensus among immunologists on the key role of regulatory T-cells in the orchestration of trophoblastic invasion at the maternal-fetal interface, while they represent some 10% of the immunological cellular repertoire at the site of implantation (NK cells representing 70%). On the vascular side, the upregulation of carbon monoxide CO, metabolite of heme oxygenase-1 (HO-1; by inhibiting soluble Flt-1, SFlt-1, and soluble endoglin, SEng, release), explains the very promising protective and potentially therapeutic effect of pravastatin in preeclampsia and the paradoxical strong protective effect of cigarette smoking on preeclampsia. Finally, there was, through a study performed on Mauritius island a great interest in the inositol phosphoglycans P-type (IPG-P) as a reliable, cheap, and predictive urinary test in preeclamptic women (a few weeks before the clinical onset of the disease). Besides the interest of a specific test, IPG-P may also partially explain the global endothelial cell disease encountered in preeclampsia. Furthermore, the Appendix of this paper lists the programs of all the workshops that have taken place since 1998.
Copyright © 2013. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Epidemiology; Immunology; Inositol phospho glycans; Preeclampsia

Mesh:

Year:  2013        PMID: 23972718     DOI: 10.1016/j.jri.2013.06.003

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  2 in total

1.  Complement factor B activation in patients with preeclampsia.

Authors:  Ivan Velickovic; Mudar Dalloul; Karen A Wong; Olufunke Bakare; Franz Schweis; Maya Garala; Amit Alam; Giorgio Medranda; Jovana Lekovic; Waqas Shuaib; Andreas Tedjasukmana; Perry Little; Daniel Hanono; Ruvini Wijetilaka; Jeremy Weedon; Jun Lin; Roulhac d'Arby Toledano; Ming Zhang
Journal:  J Reprod Immunol       Date:  2015-01-03       Impact factor: 4.054

2.  Potential of Immune-Related Genes as Biomarkers for Diagnosis and Subtype Classification of Preeclampsia.

Authors:  Ying Wang; Zhen Li; Guiyu Song; Jun Wang
Journal:  Front Genet       Date:  2020-12-01       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.